DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants
COPENHAGEN, Denmark, 24 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby invites shareholders and warrant holders to a presentation and Q/A session regarding the ongoing warrant exercise period.In connection with the exercise period of DanCann Pharma’s warrants of series TO 2 the Company invite shareholders and warrant holders to an investor presentation and Q&A that will be held by CEO Jeppe Krog Rasmussen. The investor presentation and Q&A session will take place on Friday, May 4th, from 10:00 PM to 10.45